Edesa Biotech, Inc. (EDSA)
4.76
0.00 (0.00%)
USD |
NASDAQ |
Sep 03, 16:00
4.76
0.00 (0.00%)
After-Hours: 18:24
Edesa Biotech Total Assets (Quarterly) : 12.72M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.72M |
| March 31, 2026 | 12.38M |
| December 31, 2025 | 14.71M |
| September 30, 2025 | 13.66M |
| June 30, 2025 | 14.80M |
| March 31, 2025 | 16.45M |
| December 31, 2024 | 4.164M |
| September 30, 2024 | 3.94M |
| June 30, 2024 | 5.228M |
| March 31, 2024 | 6.475M |
| December 31, 2023 | 7.832M |
| September 30, 2023 | 9.123M |
| June 30, 2023 | 9.420M |
| March 31, 2023 | 10.67M |
| December 31, 2022 | 11.67M |
| September 30, 2022 | 11.58M |
| June 30, 2022 | 17.54M |
| March 31, 2022 | 20.41M |
| December 31, 2021 | 12.34M |
| September 30, 2021 | 14.58M |
| June 30, 2021 | 16.88M |
| March 31, 2021 | 24.00M |
| December 31, 2020 | 10.29M |
| September 30, 2020 | 10.76M |
| June 30, 2020 | 8.923M |
| Date | Value |
|---|---|
| March 31, 2020 | 7.633M |
| December 31, 2019 | 5.089M |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | 9.151M |
| December 31, 2018 | 10.50M |
| September 30, 2018 | 11.78M |
| June 30, 2018 | 12.80M |
| March 31, 2018 | 5.330M |
| December 31, 2017 | 6.593M |
| September 30, 2017 | 7.72M |
| June 30, 2017 | 9.022M |
| March 31, 2017 | 10.22M |
| December 31, 2016 | 11.47M |
| September 30, 2016 | 12.94M |
| June 30, 2016 | 8.50M |
| March 31, 2016 | 9.429M |
| December 31, 2015 | 10.35M |
| September 30, 2015 | 10.39M |
| June 30, 2015 | 11.21M |
| March 31, 2015 | 11.83M |
| December 31, 2014 | 13.43M |
| August 31, 2014 | 14.47M |
| May 31, 2014 | 15.51M |
| February 28, 2014 | 16.53M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ProMIS Neurosciences, Inc. | 56.69M |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.91M |
| Shareholders Equity (Quarterly) | 8.811M |
| Current Ratio | 2.757 |